188 related articles for article (PubMed ID: 2195925)
1. Methods of theophylline assay and therapeutic monitoring of this drug.
Mounié J; Richard L; Ribon B; Hersant J; Sarmini H; Houin G
Ann Biol Clin (Paris); 1990; 48(5):287-93. PubMed ID: 2195925
[TBL] [Abstract][Full Text] [Related]
2. [Determination of theophylline, phenobarbital and valproic acid by chromatographic and immunologic technics. Comparison of methods].
Vinçon G; Demotes-Mainard F; Bistue C; Jarry C; Brachet-Liermain A; Albin H
Ann Biol Clin (Paris); 1984; 42(6):427-32. PubMed ID: 6442547
[TBL] [Abstract][Full Text] [Related]
3. Plasmatic levels of theophylline in asthmatic patients. Comparative evaluations of two different methods.
Juárez-Olguín H; Flores-Pérez J; Lares-Asseff I
Arch Med Res; 1998; 29(1):45-50. PubMed ID: 9556922
[TBL] [Abstract][Full Text] [Related]
4. Assay of theophylline: in vivo and in vitro evaluation of dry chemistry and immunoassay versus high-performance liquid chromatography.
Wallinder H; Gustafsson LL; Angbäck K; Höglund P; Magnusson A; Arvanius L
Ther Drug Monit; 1991 May; 13(3):233-9. PubMed ID: 1926277
[TBL] [Abstract][Full Text] [Related]
5. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography.
Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M
J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367
[TBL] [Abstract][Full Text] [Related]
6. Simple and rapid estimation of serum theophylline concentration using apoenzyme reactivation immunoassay.
Morikawa A; Tajima K; Mitsuhashi M; Tokuyama K; Mochizuki H; Kuroume T
Ann Allergy; 1985 Jul; 55(1):72-4. PubMed ID: 3893234
[TBL] [Abstract][Full Text] [Related]
7. [Enzyme immunoassay of drug in blood (serum)].
Nishihara K
Nihon Rinsho; 1995 Sep; 53(9):2301-9. PubMed ID: 7474397
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum theophylline concentrations measured by high pressure liquid chromatography and quantitative enzyme-multiplied immunoassay technique.
Sheen AE; Sly RM; Hite S; Giblin VR; Hebert M
Ann Allergy; 1979 Feb; 42(2):77-9. PubMed ID: 369408
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatographic analysis of phenobarbital, phenytoin, and theophylline.
Hannak D; Haux P; Scharbert F; Kattermann R
Wien Klin Wochenschr Suppl; 1992; 191():27-31. PubMed ID: 1509749
[TBL] [Abstract][Full Text] [Related]
10. Particle-enhanced turbidimetric inhibition immunoassay for theophylline evaluated with the Du Pont aca.
Opheim KE; Glick MR; Ou CN; Ryder KW; Hood LC; Ainardi V; Collymore LA; DeArmas W; Frawley VL; Hutchinson J
Clin Chem; 1984 Nov; 30(11):1870-4. PubMed ID: 6386231
[TBL] [Abstract][Full Text] [Related]
11. Serum theophylline assay by rate nephelometric inhibition immunoassay: a comparison with high-performance liquid chromatography.
Samoszuk M; Kaplan E; Finkle HI
Ther Drug Monit; 1983; 5(1):113-6. PubMed ID: 6342212
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Du Pont Theophylline Assay adapted to a centrifugal analyzer.
Boeckx RL; Munson ST
Ther Drug Monit; 1985; 7(1):95-100. PubMed ID: 3887672
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
[TBL] [Abstract][Full Text] [Related]
14. Specific methods for theophylline assay in biological samples.
Edholm LE
Eur J Respir Dis Suppl; 1980; 109():45-53. PubMed ID: 7002578
[TBL] [Abstract][Full Text] [Related]
15. Comparison between theophylline analysis by nephelometric inhibition immunoassay and high performance liquid chromatography.
Mordelet-Dambrine M; Baglin JY; Roux A; Dusser D; Flouvat B; Huchon G
Ther Drug Monit; 1986; 8(1):106-10. PubMed ID: 3961886
[TBL] [Abstract][Full Text] [Related]
16. Comparison of particle-enhanced turbidimetric inhibition immunoassay and fluorescence polarization immunoassay using monoclonal antibodies for theophylline.
Lawrence JL; Elser RC
Ther Drug Monit; 1986; 8(2):228-31. PubMed ID: 3726940
[TBL] [Abstract][Full Text] [Related]
17. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial for therapeutic drug monitoring using microchip-based fluorescence polarization immunoassay.
Tachi T; Hase T; Okamoto Y; Kaji N; Arima T; Matsumoto H; Kondo M; Tokeshi M; Hasegawa Y; Baba Y
Anal Bioanal Chem; 2011 Oct; 401(7):2301-5. PubMed ID: 21837465
[TBL] [Abstract][Full Text] [Related]
19. Analytical methods for therapeutic drug monitoring.
Boguslaski RC; Burd JF
Am J Med Technol; 1983 Aug; 49(8):551-6. PubMed ID: 6670670
[TBL] [Abstract][Full Text] [Related]
20. Analyses of the pattern of therapeutic drug monitoring in a university hospital laboratory. Suitability and performance of the CEDIA assays.
Hänseler E; Bigler S; Wad N
Wien Klin Wochenschr Suppl; 1992; 191():23-6. PubMed ID: 1509748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
